SAN DIEGO, Feb. 05, 2018-- In a presentation and in scheduled meetings with members of the investment community in New York next week, Conatus Pharmaceuticals Inc. President, Chief Executive Officer and ...

When Conatus Pharmaceuticals Inc (NASDAQ:CNAT) released its most recent earnings update (30 September 2017), I compared it against two factor: its historical earnings track record, and the performance of itsRead More...

The San Diego-based company said it had a loss of 13 cents per share. The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a ...

NEW YORK, NY / ACCESSWIRE / November 1, 2017 / Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 1, 2017 at 4:30 PM ...

David Stemerman is winding down his hedge fund firm to explore a run for governor of Connecticut, according to a letter sent to clients of Conatus Capital Management LP on Tuesday. "Connecticut – home to my family and business – is in crisis," Stemerman wrote in the note, which was viewed by Reuters. The next election for governor in Connecticut is in November 2018.

On a per-share basis, the San Diego-based company said it had a loss of 19 cents. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment ...